The AI Dilemma in Indian Healthcare: 48% of Clinicians Use AI, but Few Rely on Tools Built for Medicine

 Published July 22, 2026

Artificial intelligence is rapidly shifting from experimental technology to everyday workplace reality across India’s health sector. However, a growing divide between how clinicians use AI and the safety standards required for patient care has sparked critical debate among health experts.

On July 20, 2026, global health publisher Elsevier released its landmark Clinician of the Future 2026 report. The survey revealed that while 48% of Indian doctors and clinicians now use AI tools in their daily work, only 26% regularly utilize clinical-specific platforms designed explicitly for healthcare. Instead, the majority—54% of AI-using clinicians in India—rely on general-purpose chatbots and public language models.

This gap between widespread adoption and clinical validation raises urgent questions regarding diagnostic accuracy, patient privacy, and medical liability. As AI deployment outpaces institutional training, public health leaders are urging immediate action to safeguard patient care.

Unpacking the Survey: Fast Adoption, Generic Tools

The Clinician of the Future 2026 report, which surveyed 2,757 clinicians across 118 countries—including 426 doctors and 112 paramedics in India—paints a dynamic picture of modern medical practice. AI is no longer a distant vision; it is embedded in daily workflows.

According to the data, Indian clinicians primarily use AI to assist with six main tasks:

• Medical research (57%)

• Professional education (57%)

• Identifying drug information (50%)

• Patient education (46%)

• Clinical decision support (40%)

• Clinical documentation (40%)

While these numbers demonstrate that AI is helping physicians save time on literature reviews and administrative tasks, the reliance on off-the-shelf consumer AI remains high.

Why the Gap Matters: Generic Chatbots vs. Clinical-Specific AI

Public large language models (LLMs) are designed to generate natural, conversational text based on statistical probabilities. However, they are not naturally built to uphold strict medical evidence standards, verify sources against peer-reviewed journals, or guard against “hallucinations”—instances where the AI generates plausible-sounding but factually incorrect information.

In contrast, clinical-specific AI tools are built on vetted, peer-reviewed medical databases. They offer source attribution, transparent references, and strict algorithmic guardrails designed to support life-critical decisions.

“Many clinicians are turning to generic LLMs during clinical workflow,” explained Dr. Rahul Goyal, lead clinical executive at Elsevier and a veteran physician. “They can produce very confident answers, but a confident answer is not necessarily the correct one.”

Dr. Goyal highlighted a critical concept known as the “liability sink.” When a clinician uses an unvalidated AI tool that delivers flawed advice, the AI bears no legal or ethical responsibility. The clinical liability rests solely on the treating physician.

Dr. G.C. Khilnani, Chairman of the PSRI Institute of Pulmonary, Critical Care, and Sleep Medicine and former professor at AIIMS, reiterated that human acumen must remain central:

“Medicine is both science and art, and AI cannot replicate a physician’s clinical acumen or recognize every atypical presentation,” Dr. Khilnani noted. “The responsibility for patient care will always rest with the doctor.”

Global Context: High Trust, Uneven Training

The trend observed in India reflects broader international developments while showcasing unique regional characteristics.

Globally, 49% of healthcare workers report using AI at work, with 80% expressing confidence that AI will serve as a vital clinical assistant within the next decade. In the United States, a 2026 survey by the American Medical Association (AMA) found that 81% of U.S. physicians now use AI professionally, primarily for summarizing medical literature, drafting visit notes, and generating discharge instructions.

Interestingly, Indian clinicians exhibit higher overall trust in AI systems (43%) than their peers in Western nations, such as the UK (21%) or the US (19%). Furthermore, 53% of Indian respondents reported having good institutional AI governance, compared to the global average of 40%.

                  AI Adoption at Work vs. Clinical Tool Reliance
       ------------------------------------------------------------------
       Global Clinicians Using AI at Work         : 49%
       Indian Clinicians Using AI at Work         : 48% (or 42% in subgroups)
       Indian Clinicians Using General AI         : 54%
       Indian Clinicians Using Clinical AI        : 26%
       ------------------------------------------------------------------

Despite this optimism, severe training deficits persist. Reporting from the Elsevier dataset indicates that only 18% of doctors felt they had received adequate AI training, compared with 46% of nurses.

This aligns with independent peer-reviewed research published in India involving 250 medical students and clinicians. The study found that fewer than half believed AI could currently assist with direct diagnosis or treatment, and 82.9% had never completed a formal course on medical AI.

Public Health Implications for Patients and Health Systems

For patients, the rapid integration of AI into clinics is a double-edged sword. On one hand, AI can help doctors spend less time staring at computer screens typing notes and more time listening to patients. It can also help bridge healthcare access gaps between metropolitan tertiary hospitals and under-resourced rural clinics by providing standardized medical guidance.

On the other hand, patients must understand that general AI tools are not stand-alone diagnostic authorities. Expert recommendations for health systems and clinicians include:

1. Mandatory Clinical Verification: Clinicians must cross-check any AI-assisted draft or research summary against established medical guidelines before altering patient care.

2. Transparent Procurement: Hospitals must implement clear screening processes for AI software, prioritizing platforms built on validated medical literature.

3. Structured Medical Education: Medical schools and continuing education programs must introduce mandatory training on ethical AI usage, bias recognition, and data privacy.

Limitations to Consider

While these findings offer vital insights, notable limitations exist:

• Self-Reported Data: The Elsevier report relies on self-reported survey responses from clinicians rather than direct, observational studies of clinical practice.

• Definition Variations: Interpretations of what constitutes “AI use” or “clinical-specific tools” can vary among individual survey participants.

• Sample Size Scope: While the sample of 2,757 respondents globally provides strong directional data, care should be taken when generalizing results across diverse regional healthcare settings.

References

1. Times of India. AI is helping India doctors. But are they using the right tools? Published July 21, 2026.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.